Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Ogenix Corp.
Acquisitions, New Technologies Reshaping Advanced Wound Care
Acquisitions and innovation are rapidly changing the dynamics in the global advanced wound care market, a high need, high growth market estimated at $5.4 billion in 2013. With the number of chronic wounds in major countries estimated at a whopping 26.7 million, the global advanced wound care market is projected to grow at a brisk 6% CAGR, reaching $7.3 billion by 2018.
FDA Close-Out Letters
Close-out letters posted on the agency’s website from Oct. 8 through Nov. 12.
FDA Warning Letters
H&H Wholesale Services cited for QS and MDR reg violations in relation to OneTouch and One Step Test Strips.
Biologics: The Growth Engine In Advanced Wound Care
With estimated revenues in excess of $5 billion per year worldwide, the advanced wound care market has garnered the attention of both major companies and investors for its tremendous potential. Growth in this market is being driven by the development of new bioactive products that can successfully heal chronic wounds such as diabetic foot ulcers, which are among the most challenging and costly to treat. This article is reprinted from the June issue of Medtech Insight.
- Medical Devices
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.